1. Home
  2. XELB vs NRSN Comparison

XELB vs NRSN Comparison

Compare XELB & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xcel Brands Inc.

XELB

Xcel Brands Inc.

HOLD

Current Price

$1.17

Market Cap

10.6M

Sector

Miscellaneous

ML Signal

HOLD

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.89

Market Cap

29.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XELB
NRSN
Founded
2011
2017
Country
United States
Israel
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
29.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
XELB
NRSN
Price
$1.17
$0.89
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$3.00
$14.00
AVG Volume (30 Days)
53.6K
491.6K
Earning Date
11-19-2025
04-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,980,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$83.93
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.74
$0.81
52 Week High
$7.40
$2.60

Technical Indicators

Market Signals
Indicator
XELB
NRSN
Relative Strength Index (RSI) 56.87 37.31
Support Level $0.91 $0.86
Resistance Level $1.21 $1.24
Average True Range (ATR) 0.08 0.12
MACD 0.05 -0.03
Stochastic Oscillator 87.29 7.55

Price Performance

Historical Comparison
XELB
NRSN

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: